Cancer Research and Treatment

Cancer Research and Treatment Search

> Browse Articles > Search

Gastrointestinal cancer

Hepatitis B Virus Core Protein Mediates the Upregulation of C5α Receptor 1 via NF-κB Pathway to Facilitate the Growth and Migration of Hepatoma Cells

Fanyun Kong, Yukai Tao, Dongchen Yuan, Ning Zhang, Qi Li, Tong Yu, Xiaoying Yang, Delong Kong, Xiaohui Ding, Xiangye Liu, Hongjuan You, Kuiyang Zheng, Renxian Tang

Cancer Res Treat. 2021;53(2):506-527. Published online November 16, 2020 DOI: https://doi.org/10.4143/crt.2020.397

Cited By 5

Hyperammonemic Encephalopathy Mimicking Ornithine Transcarbamylase Deficiency in Fibrolamellar Hepatocellular Carcinoma: Successful Treatment with Continuous Venovenous Hemofiltration and Ammonia Scavengers

Jeong-Seon Lee, Hye Young Jin, Jung Min Ko, Seoung Hoon Kim, Nayoung Han, Byung Kiu Park, Meerim Park, Hyeon Jin Park, Jun Ah Lee

Cancer Res Treat. 2021;53(1):283-288. Published online September 7, 2020 DOI: https://doi.org/10.4143/crt.2020.575

Cited By 8

Gastrointestinal cancer

Evaluation of the American Joint Committee on Cancer (AJCC) 8th Edition Staging System for Hepatocellular Carcinoma in 1,008 Patients with Curative Resection

Sujin Park, Sangjoon Choi, Yoon Ah Cho, Dong Hyun Sinn, Jong Man Kim, Cheol-Keun Park, Sang Yun Ha

Cancer Res Treat. 2020;52(4):1145-1152. Published online April 28, 2020 DOI: https://doi.org/10.4143/crt.2020.208

Cited By 14

Prognostic Value of TP53 Mutation for Transcatheter Arterial Chemoembolization Failure/Refractoriness in HBV-Related Advanced Hepatocellular Carcinoma

Miao Xue, Yanqin Wu, Wenzhe Fan, Jian Guo, Jialiang Wei, Hongyu Wang, Jizhou Tan, Yu Wang, Wang Yao, Yue Zhao, Jiaping Li

Cancer Res Treat. 2020;52(3):925-937. Published online March 30, 2020 DOI: https://doi.org/10.4143/crt.2019.533

Cited By 7

Soluble Axl Is a Novel Diagnostic Biomarker of Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection

Xiaoting Song, Ailu Wu, Zhixiao Ding, Shixiong Liang, Chunyan Zhang

Cancer Res Treat. 2020;52(3):789-797. Published online March 5, 2020 DOI: https://doi.org/10.4143/crt.2019.749

Cited By 9

Activation of Tyrosine Metabolism in CD13⁺ Cancer Stem Cells Drives Relapse in Hepatocellular Carcinoma

Li Sun, Lin Zhang, Jun Chen, Chaoqun Li, Hongqin Sun, Jiangrong Wang, Hong Xiao

Cancer Res Treat. 2020;52(2):604-621. Published online December 27, 2019 DOI: https://doi.org/10.4143/crt.2019.444

Cited By 19

Cathepsin C Interacts with TNF-α/p38 MAPK Signaling Pathway to Promote Proliferation and Metastasis in Hepatocellular Carcinoma

Guo-Pei Zhang, Xiao Yue, Shao-Qiang Li

Cancer Res Treat. 2020;52(1):10-23. Published online April 26, 2019 DOI: https://doi.org/10.4143/crt.2019.145

Cited By 25

Treatment Outcome after Fractionated Conformal Radiotherapy for Hepatocellular Carcinoma in Patients with Child-Pugh Classification B in Korea (KROG 16-05)

Sun Hyun Bae, Hee Chul Park, Won Sup Yoon, Sang Min Yoon, In-Hye Jung, Ik Jae Lee, Jun Won Kim, Jinsil Seong, Tae Hyun Kim, Taek-Keun Nam, Youngmin Choi, Sun Young Lee, Hong Seok Jang, Dong Soo Lee, Jin Hee Kim

Cancer Res Treat. 2019;51(4):1589-1599. Published online April 10, 2019 DOI: https://doi.org/10.4143/crt.2018.687

Cited By 12

Novel Prognostic Nomograms Based on Inflammation-Related Markers for Patients with Hepatocellular Carcinoma Underwent Hepatectomy

Yifei Wang, Kaiyu Sun, Jingxian Shen, Bin Li, Ming Kuang, Qinghua Cao, Sui Peng

Cancer Res Treat. 2019;51(4):1464-1478. Published online March 11, 2019 DOI: https://doi.org/10.4143/crt.2018.657

Cited By 20

Surveillance Rate and its Impact on Survival of Hepatocellular Carcinoma Patients in South Korea: A Cohort Study

Sanghyuk Im, Eun Sun Jang, Ju Hyun Lee, Chung Seop Lee, Beom Hee Kim, Jung Wha Chung, Jin-Wook Kim, Sook-Hyang Jeong

Cancer Res Treat. 2019;51(4):1357-1369. Published online February 12, 2019 DOI: https://doi.org/10.4143/crt.2018.430

Cited By 4

Phase I Dose-Finding Study of OPB-111077, a Novel STAT3 Inhibitor, in Patients with Advanced Hepatocellular Carcinoma

Changhoon Yoo, Jihoon Kang, Ho Yeong Lim, Jee Hyun Kim, Myung-Ah Lee, Kyung-Hun Lee, Tae-You Kim, Baek-Yeol Ryoo

Cancer Res Treat. 2019;51(2):510-518. Published online June 13, 2018 DOI: https://doi.org/10.4143/crt.2018.226

Cited By 30

Hepatic Resection Provides Survival Benefit for Selected Intermediate-Stage (BCLC-B) Hepatocellular Carcinoma Patients

Zhang Zhaohui, Shen Shunli, Chen Bin, Li Shaoqiang, Hua Yunpeng, Kuang Ming, Liang Lijian, Peng Bao Gang

Cancer Res Treat. 2019;51(1):65-72. Published online February 26, 2018 DOI: https://doi.org/10.4143/crt.2018.038

Cited By 13

Everolimus Plus Ku0063794 Regimen Promotes Anticancer Effects against Hepatocellular Carcinoma Cells through the Paradoxical Inhibition of Autophagy

Sang Chul Lee, Kee-Hwan Kim, Ok-Hee Kim, Sang Kuon Lee, Ha-Eun Hong, Byung Jo Choi, Wonjun Jeong, Say-June Kim

Cancer Res Treat. 2018;50(3):1023-1038. Published online November 9, 2017 DOI: https://doi.org/10.4143/crt.2017.085

Cited By 6

Sarcopenia Predicts Prognosis in Patients with Newly Diagnosed Hepatocellular Carcinoma, Independent of Tumor Stage and Liver Function

Yeonjung Ha, Daejung Kim, Seungbong Han, Young Eun Chon, Yun Bin Lee, Mi Na Kim, Joo Ho Lee, Hana Park, Kyu Sung Rim, Seong Gyu Hwang

Cancer Res Treat. 2018;50(3):843-851. Published online September 4, 2017 DOI: https://doi.org/10.4143/crt.2017.232

Cited By 30

Inter-alpha Inhibitor H4 as a Potential Biomarker Predicting the Treatment Outcomes in Patients with Hepatocellular Carcinoma

Eun-Jung Lee, Seung-Hyun Yang, Kyoung-Jin Kim, Hyejung Cha, Seo Jin Lee, Ji-Hye Kim, Junkyu Song, Kyung-Hee Chun, Jinsil Seong

Cancer Res Treat. 2018;50(3):646-657. Published online July 17, 2017 DOI: https://doi.org/10.4143/crt.2016.550

Cited By 10

Body Composition Predicts Survival in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization

Neehar D. Parikh, Peng Zhang, Amit G. Singal, Brian A. Derstine, Venkat Krishnamurthy, Pranab Barman, Akbar K. Waljee, Grace L. Su

Cancer Res Treat. 2018;50(2):530-537. Published online June 1, 2017 DOI: https://doi.org/10.4143/crt.2017.156

Cited By 18

Sub-classification of Advanced-Stage Hepatocellular Carcinoma: A Cohort Study Including 612 Patients Treated with Sorafenib

Jeong-Ju Yoo, Goh Eun Chung, Jeong-Hoon Lee, Joon Yeul Nam, Young Chang, Jeong Min Lee, Dong Ho Lee, Hwi Young Kim, Eun Ju Cho, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Seoul Liver Group

Cancer Res Treat. 2018;50(2):366-373. Published online May 15, 2017 DOI: https://doi.org/10.4143/crt.2017.126

Cited By 14

Overexpression of PD-L1 and PD-L2 Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma

Hae Il Jung, Dongjun Jeong, Sanghee Ji, Tae Sung Ahn, Sang Ho Bae, Susie Chin, Jun Chul Chung, Hyung Chul Kim, Moon Soo Lee, Moo-Jun Baek

Cancer Res Treat. 2017;49(1):246-254. Published online July 7, 2016 DOI: https://doi.org/10.4143/crt.2016.066

Cited By 124

Studying the Effect of Downregulating Autophagy-Related Gene LC3 on TLR3 Apoptotic Pathway Mediated by dsRNA in Hepatocellular Carcinoma Cells

Guilan Wang, Maona Zhang, Yunlong Li, Jiaming Zhou, Li Chen

Cancer Res Treat. 2017;49(1):230-245. Published online June 13, 2016 DOI: https://doi.org/10.4143/crt.2015.506

Cited By 3

Clinical Practice Patterns of Radiotherapy in Patients with Hepatocellular Carcinoma: A Korean Radiation Oncology Group Study (KROG 14-07)

Hyejung Cha, Hee Chul Park, Jeong Il Yu, Tae Hyun Kim, Taek-Keun Nam, Sang Min Yoon, Won Sup Yoon, Jun Won Kim, Mi Sook Kim, Hong Seok Jang, Youngmin Choi, Jin Hee Kim, Chul Seung Kay, Inkyung Jung, Jinsil Seong

Cancer Res Treat. 2017;49(1):61-69. Published online June 13, 2016 DOI: https://doi.org/10.4143/crt.2016.097

Cited By 11

Estimation of the Incidence of Hepatocellular Carcinoma and Cholangiocarcinoma in Songkhla, Thailand, 1989-2013, Using Multiple Imputation Method

Seesai Yeesoonsang, Surichai Bilheem, Edward McNeil, Sophon Iamsirithaworn, Chuleeporn Jiraphongsa, Hutcha Sriplung

Cancer Res Treat. 2017;49(1):54-60. Published online May 18, 2016 DOI: https://doi.org/10.4143/crt.2016.045

Cited By 5

Real-Life Experience of Sorafenib Treatment for Hepatocellular Carcinoma in Korea: From GIDEON Data

Do Young Kim, Hye Jin Kim, Kwang-Hyub Han, Sang Young Han, Jeong Heo, Hyun Young Woo, Soon Ho Um, Yeul Hong Kim, Young Oh Kweon, Ho Yeong Lim, Jung Hwan Yoon, Wan Sik Lee, Byung Seok Lee, Han Chu Lee, Baek-Yeol Ryoo, Seung Kew Yoon

Cancer Res Treat. 2016;48(4):1243-1252. Published online February 24, 2016 DOI: https://doi.org/10.4143/crt.2015.278

Cited By 14

A New Cell Block Method for Multiple Immunohistochemical Analysis of Circulating Tumor Cells in Patients with Liver Cancer

Soo Jeong Nam, Hyun Yang Yeo, Hee Jin Chang, Bo Hyun Kim, Eun Kyung Hong, Joong-Won Park

Cancer Res Treat. 2016;48(4):1229-1242. Published online March 30, 2016 DOI: https://doi.org/10.4143/crt.2015.500

Cited By 11

The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis

Sang Yun Ha, Jeong Hoon Kim, Jung Wook Yang, Jimin Kim, Binnari Kim, Cheol-Keun Park

Cancer Res Treat. 2016;48(3):1065-1073. Published online October 16, 2015 DOI: https://doi.org/10.4143/crt.2015.302

Cited By 8

Do Biliary Complications after Hypofractionated Radiation Therapy in Hepatocellular Carcinoma Matter?

Jeong Il Yu, Hee Chul Park, Do Hoon Lim, Seung Woon Paik

Cancer Res Treat. 2016;48(2):574-582. Published online July 17, 2015 DOI: https://doi.org/10.4143/crt.2015.076

Cited By 10

Clinical Benefit of Hepatic Arterial Infusion Concurrent Chemoradiotherapy in Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis

Hong In Yoon, Ki Jun Song, Ik Jae Lee, Do Young Kim, Kwang-Hyub Han, Jinsil Seong

Cancer Res Treat. 2016;48(1):190-197. Published online March 5, 2015 DOI: https://doi.org/10.4143/crt.2014.276

Cited By 13

The Prognostic Role of Mitotic Index in Hepatocellular Carcinoma Patients after Curative Hepatectomy

Sang Yun Ha, Misun Choi, Taebum Lee, Cheol-Keun Park

Cancer Res Treat. 2016;48(1):180-189. Published online March 18, 2015 DOI: https://doi.org/10.4143/crt.2014.321

Cited By 10

ATAD2 as a Poor Prognostic Marker for Hepatocellular Carcinoma after Curative Resection

Hye Won Hwang, Sang Yun Ha, Heejin Bang, Cheol-Keun Park

Cancer Res Treat. 2015;47(4):853-861. Published online February 16, 2015 DOI: https://doi.org/10.4143/crt.2014.177

Cited By 30

Expression of PEG10 Is Associated with Poor Survival and Tumor Recurrence in Hepatocellular Carcinoma

Heejin Bang, Sang Yun Ha, Soo Hyun Hwang, Cheol-Keun Park

Cancer Res Treat. 2015;47(4):844-852. Published online February 13, 2015 DOI: https://doi.org/10.4143/crt.2014.124

Cited By 27

Changes in Arterioportal Shunts in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis Who Were Treated with Chemoembolization Followed by Radiotherapy

Dongryul Oh, Sung Wook Shin, Hee Chul Park, Sung Ki Cho, Do Hoon Lim, Seung Woon Paik

Cancer Res Treat. 2015;47(2):251-258. Published online October 27, 2014 DOI: https://doi.org/10.4143/crt.2014.011

Cited By 12